Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1 1

Status

Completed 3Recruiting 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Vaping 1Uterine Cervical Dysplasia 1Smoking Cessation 1Pain 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Transdermal Patch × Clear all
NCT01989923 2026-04-07

Smoking Cessation in Women With Gynecological Conditions

University of Oklahoma

Phase NA Completed
31 enrolled
Gynecologic

Vaping, Uterine Cervical Dysplasia, Smoking Cessation

NCT02192021 2024-08-09

MNA-D

University of Pittsburgh

Phase 1 Completed
20 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT00644787 2013-06-13

A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain

Janssen Pharmaceutical K.K.

Phase 2/3 Completed
156 enrolled 14 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡